Skip to main content
Clinical Trials/NL-OMON54043
NL-OMON54043RecruitingNot Applicable

Aerobic fitness or Muscle mass training to Improve Colorectal cancer Outcomes (AMICO): to study safe and feasible exercise dosages (phase 2) and the effects of exercise on chemotherapy dose modifications and progression free survival (phase 3) in patients with metastatic colorectal cancer. - AMICO

Radboud Universitair Medisch Centrum0 sites228 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
228

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • -age >=18 years;
  • -mCRC with indication for chemotherapy, with initially unresectable metastatic
  • -scheduled for treatment with first-line doublet or triplet chemotherapy,
  • according to the national guideline
  • -able and willing to give written informed consent.

Exclusion Criteria

  • -life expectancy <6 months
  • -unable to perform basic activities of daily living such as walking or biking
  • -presence of cognitive disorders or severe emotional instability (e.g.,
  • Schizophrenia, Alzheimer, alcohol addiction);
  • -presence of other disabling co-morbidities that might hamper physical exercise
  • (e.g. heart failure (NYHA classes 3 and 4), chronic obstructive pulmonary
  • disease (COPD, gold 3 and 4), orthopaedic conditions and neurological disorders
  • (e.g., hernia, paresis, amputation, active rheumatoid arthritis);
  • -insufficient mastery of the Dutch language;
  • -presence of serious cardiovascular or cardiopulmonary conditions (e.g.
  • unstable angina, arrhythmia or valve disease) such that exercise safety is at
  • risk, as judged by the treating physician.
  • -Already participating in structured vigorous aerobic and/or resistance
  • exercise >= 2 times per week comparable to our intervention

Investigators

Similar Trials